Why BGPT?
logo

Best evidence across studies

Locate the most directly supported claims with linked experiments, exact results, and known limitations for decision use.Know what the science actually supports before you trust the answer.

Press Enter ↡ to find evidence


     Quick Answer



    ATP is an allosteric inhibitor: high ATP stabilizes the less-active PFK-1 state and lowers glycolytic flux. Fructose-2,6-bisphosphate (F-2,6-BP) is a potent activator: it increases PFK-1 activity and counteracts ATP inhibition, thereby increasing flux. Structural and biochemical analyses support reciprocal regulation by ATP, citrate, and F-2,6-BP.


     Long Answer



    Two allosteric regulators

    1. ATP β€” inhibitor
    When cellular energy charge is high, ATP binds regulatory sites on PFK-1 and decreases its apparent affinity for fructose-6-phosphate. The enzyme therefore operates more slowly, reducing conversion of fructose-6-phosphate to fructose-1,6-bisphosphate and lowering glycolytic flux. ATP inhibition is physiologically coherent as feedback: abundant ATP signals reduced immediate need for substrate-level glycolytic ATP production. Citrate can reinforce this inhibition, although citrate is not counted as one of the two regulators here.
    2. Fructose-2,6-bisphosphate β€” activator
    F-2,6-BP binds a regulatory site on PFK-1 and strongly increases enzyme activity, including under conditions in which ATP would otherwise inhibit the enzyme. This shifts PFK-1 toward its active state, increasing fructose-1,6-bisphosphate formation and generally increasing glycolytic flux. Its concentration is controlled by the bifunctional PFK-2/FBPase-2 system, so hormonal and nutritional signals can regulate glycolysis indirectly by changing F-2,6-BP abundance.

    Important qualification

    β€œMain control point” is useful shorthand, not an absolute rule: measured glycolytic flux also depends on substrate supply, product removal, other irreversible steps, compartmentation, cell type, and signaling. The supplied evidence record on hypoxic cancer cells reports reduced PFK-1 gene expression after diindolylmethane exposure, but it does not directly test ATP or F-2,6-BP binding and therefore cannot serve as a direct study of these two allosteric mechanisms.

    Feedback:   

    Updated: August 07, 2026

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    PFK-1 alone determines glycolytic flux; this is too strong because upstream glucose transport, hexokinase, downstream product removal, and cell-specific pathway architecture can also become limiting.

     Science Art


    Phosphofructokinase-1 (PFK-1) is considered the "main control point" of  glycolysis. Describe two (2) allosteric regulators of PFK-1 and explain how each affects  glycolytic flux. 
Give doi of studies Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT